SEC Filing Details
Document Details
Form
Filing Date
Dec 18, 2017
Document Date
Dec 14, 2017
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Galectin Therapeutics Inc.
Issuer
GALECTIN THERAPEUTICS INC
Filer
SHULMAN STEPHEN